Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Hyperproliferation markers in ear canal epidermis.

Caliman e Gurgel JD, Pereira SB, Alves AL, Ribeiro FQ.

Braz J Otorhinolaryngol. 2010 Sep-Oct;76(5):667-71. Review. English, Portuguese.

2.

Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.

Raynov AM, Moon SK, Choung YH, Hong SP, Park K.

Am J Otolaryngol. 2005 Sep-Oct;26(5):296-301.

PMID:
16137526
3.

[Markers of epidermal proliferation in middle ear cholesteatoma].

Hassmann-Poznańska E, Skotnicka B, Dziecioł J.

Otolaryngol Pol. 2003;57(4):505-11. Polish.

PMID:
14587387
4.
5.

Epidermal differentiation in the human external auditory meatus.

Vennix PP, Kuijpers W, Peters TA, Tonnaer EL, Ramaekers FC.

Laryngoscope. 1996 Apr;106(4):470-5.

PMID:
8614223
6.

[The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].

Zhu Z, Hong Y, Wang Y, He G, Ye S.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Jan;30(2):139-43. Chinese.

PMID:
27192911
7.

[Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].

Li H, Jiang P, Wang L.

Zhonghua Er Bi Yan Hou Ke Za Zhi. 2002 Apr;37(2):118-20. Chinese.

PMID:
12768722
8.

A study on epidermal proliferation ability in cholesteatoma.

Tanaka Y, Shiwa M, Kojima H, Miyazaki H, Kamide Y, Moriyama H.

Laryngoscope. 1998 Apr;108(4 Pt 1):537-42.

PMID:
9546266
10.

Air-exposed tissue culture of human middle ear epithelium and meatal epidermis: a method to study the advancing front of cholesteatoma.

Albers-op t' Hof BM, Peek FA, Huisman MA, Grote JJ.

Acta Otolaryngol. 2002 Oct;122(7):720-5.

PMID:
12484648
11.

Overexpression of tenascin in cholesteatoma and external auditory meatal skin compared to retroauricular epidermis.

Schilling V, Lang S, Rasp G, Mack B, Nerlich A.

Acta Otolaryngol. 1996 Sep;116(5):741-6.

PMID:
8908253
12.

Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.

Woo HJ, Park JC, Bae CH, Song SY, Lee HM, Kim YD.

Acta Otolaryngol. 2009 Jun;129(6):624-9. doi: 10.1080/00016480802342457.

PMID:
18720059
13.

Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.

Sasaki H, Huang CC.

Otolaryngol Head Neck Surg. 1994 Mar;110(3):310-7.

PMID:
7510866
14.

[Evaluation of epithelial proliferation and apoptosis in cholesteatoma of adults].

Olszewska E, Chodynicki S, Chyczewski L.

Otolaryngol Pol. 2003;57(1):85-9. Polish.

PMID:
12741150
15.

Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.

Chae SW, Song JJ, Suh HK, Jung HH, Lim HH, Hwang SJ.

Laryngoscope. 2000 Nov;110(11):1898-901.

PMID:
11081606
16.

Some markers of proliferative activity in cholesteatoma epithelium in adults.

Olszewska E, Chodynicki S, Chyczewski L, Rogowski M.

Med Sci Monit. 2006 Aug;12(8):CR337-40. Epub 2006 Jul 12.

PMID:
16865065
17.

Cell proliferation and apoptosis in human middle ear cholesteatoma.

Kojima H, Tanaka Y, Tanaka T, Miyazaki H, Shiwa M, Kamide Y, Moriyama H.

Arch Otolaryngol Head Neck Surg. 1998 Mar;124(3):261-4.

PMID:
9525508
18.

Alteration of epidermal differentiation in middle ear cholesteatoma.

Stammberger M, Bujía J, Kastenbauer E.

Am J Otol. 1995 Jul;16(4):527-31.

PMID:
8588655
19.

Immunohistochemical study on proliferative activity of experimental cholesteatoma.

Park K, Park HJ, Chun YM.

Eur Arch Otorhinolaryngol. 2001 Mar;258(3):101-5.

PMID:
11374247
20.

[Comparative analysis of the proliferative capacity of cholesteatomas].

Bernal Sprekelsen M, Ebmeyer J, Buchbinder A, Sudhoff H.

Acta Otorrinolaringol Esp. 2000 May;51(4):299-307. Spanish.

PMID:
10984952

Supplemental Content

Support Center